1996
DOI: 10.1016/s0924-977x(96)00033-8
|View full text |Cite
|
Sign up to set email alerts
|

Behavioral effects of CCKB receptor ligands in a validated simulation of panic anxiety in rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

1999
1999
2016
2016

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 28 publications
(7 citation statements)
references
References 32 publications
0
7
0
Order By: Relevance
“…Whilst acute does of the SSRIs fluoxetine and fluvoxamine potentiate panic symptoms in PD patients (Saran and Halaris 1989;Denboer and Westenberg 1990), they do not increase anxiety in the dPAG stimulation model after acute administration (Jenck et al 1990(Jenck et al , 1998b. Moreover, drugs which have no effect on panic symptoms in patients, such as the CCK B antagonist L-365,260 and the antipsychotic haloperidol, have proven antiaversive in this test (Jenck et al 1989(Jenck et al , 1996. Along with mCPP, the panicogenic agent caffeine also fails to increase one-way escape in the elevated Tmaze (Graeff et al 1998).…”
Section: Discussionmentioning
confidence: 99%
“…Whilst acute does of the SSRIs fluoxetine and fluvoxamine potentiate panic symptoms in PD patients (Saran and Halaris 1989;Denboer and Westenberg 1990), they do not increase anxiety in the dPAG stimulation model after acute administration (Jenck et al 1990(Jenck et al , 1998b. Moreover, drugs which have no effect on panic symptoms in patients, such as the CCK B antagonist L-365,260 and the antipsychotic haloperidol, have proven antiaversive in this test (Jenck et al 1989(Jenck et al , 1996. Along with mCPP, the panicogenic agent caffeine also fails to increase one-way escape in the elevated Tmaze (Graeff et al 1998).…”
Section: Discussionmentioning
confidence: 99%
“…The involvement of CCK and its by products in the induction of anxiety in humans and in anxiety models in animals is well demonstrated [Van Megen et al, 1996;Jenck et al, 1996;Crawley, 1994;Costall et al, 1991]. Since the activity of CCK is mediated by, or integrated with, the activity of various neurotransmitter systems, it is quite possible that the specific blocking of CCK receptor subtypes is not sufficient to effectively attenuate clinical features of anxiety or their laboratory models.…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, compounds that failed to alleviate panic symptoms in human (i.e. the antipsychotic haloperidol and the CCKB receptor antagonist L-365,260) produced antiaversive effects in this test [56,58]. These latter ®ndings bring into question the validity of the dPAG-stimulation procedure to reveal a speci®c panic or antipanic pro®le of panic-modulating agents.…”
Section: Panic Disorder (Pd)mentioning
confidence: 94%